Imunon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Imunon and other ETFs, options, and stocks.About IMNN
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies.
CEOStacy R. Lindborg
CEOStacy R. Lindborg
Employees25
Employees25
HeadquartersLawrenceville, New Jersey
HeadquartersLawrenceville, New Jersey
Founded1982
Founded1982
Employees25
Employees25
IMNN Key Statistics
Market cap12.04M
Market cap12.04M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume26.36K
Average volume26.36K
High today$3.92
High today$3.92
Low today$3.92
Low today$3.92
Open price$3.92
Open price$3.92
Volume2.67K
Volume2.67K
52 Week high$47.40
52 Week high$47.40
52 Week low$3.56
52 Week low$3.56
Stock Snapshot
Imunon(IMNN) stock is priced at $3.92, giving the company a market capitalization of 12.04M. It carries a P/E multiple of -0.38.
During the trading session on 2025-12-10, Imunon(IMNN) shares reached a daily high of $3.92 and a low of $3.92. At a current price of $3.92, the stock is +0.1% higher than the low and still 0.0% under the high.
Trading volume for Imunon(IMNN) stock has reached 2.67K, versus its average volume of 26.36K.
Over the past 52 weeks, Imunon(IMNN) stock has traded between a high of $47.40 and a low of $3.56.
Over the past 52 weeks, Imunon(IMNN) stock has traded between a high of $47.40 and a low of $3.56.
People also own
Based on the portfolios of people who own IMNN. This list is generated using Robinhood data, and it’s not a recommendation.